openPR Logo
Press release

Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market Development Factors, Investment Analysis By Top Players like GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc. and Merck & Co., Inc.

02-05-2019 12:59 PM CET | Health & Medicine

Press release from: Allied Market Research

Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market

Increase in adoption of chemotherapeutic drugs is directly linked to the growth of the CINV drugs market. It is estimated that in 2016, approximately 1.6 million new cases of cancer will be diagnosed with breast, lung, and bronchus cancer. It is observed that approximately 35% of patients experienced nausea within 24 hours of chemotherapy, while 54% suffered from nausea and 34% experienced vomiting after 24 hours.

Growth in number of patients undergoing chemotherapy drugs treatment and introduction of new drug delivery methods to improve patient compliance are the major factors that significantly impact the growth of the CINV market. At present, pharmaceutical companies are increasingly investing in the R&D of CINV drugs to offer better chemotherapy drugs and increase their market share.Chemotherapy-induced Nausea and Vomiting (CINV) Market report, published by Allied Market Research, forecasts that the global market is expected to garner $2,659 million by 2022, growing at a CAGR of 7.1% during 2016-2022.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/1846

Chemotherapy-induced nausea and vomiting (CINV) drugs market experiences growth due to increase in number of patients undergoing chemotherapy and increased uptake of low toxicity targeted treatments. Some of the key drugs in the market are Akynzeo, Emend, Aloxi, Zofran, Kytril and SUSTOL and Rolapitant. At present, pharmaceutical companies have prioritized investment in R&D of CINV drugs for driving their profit margins and sustain the use of chemotherapeutic drugs.

Granisetron transdermal patch with the trade name Sancuso was approved by the US FDA. It is manufactured by 3M Drug Delivery Systems. Granisetron is a selective inhibitor of type 3 serotonergic (5-HT3) receptors. It has little or no affinity for other serotonin receptors, including 5-HT 1, 5-HT 1A, 5-HT, or 5-HT 2. The cancer population living in the developing economies of LAMEA and Asia-Pacific are adopting novel CINV drug delivery methods such as combination therapies and transdermal patches to minimize the side effects of chemotherapeutic drugs. CINV market in North America generates the largest share of global CINV drugs market, followed by Europe and Asia-Pacific. The demand for CINV drugs market in Asia-Pacific market is expected to post the fastest growth for CINV drugs market.

Top Key Players :

• GlaxoSmithKline plc
• Helsinn Holding S.A.
• Heron Therapeutics Inc.
• Merck & Co. Inc.
• Tesaro Inc

The North American market has witnessed a significant growth in the recent years. Presently, it is the largest regional market for CINV drugs and an its market share is anticipated by 2022. Asia-Pacific is the fastest growing market due to increase in number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting. This region boosts up the demand for antiemetic drug due to growth in demand for CINV drugs and is expected to fuel the market growth in this region.
Partnership and collaboration is the key strategy adopted by companies to strengthen their position in the market.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1846

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market Development Factors, Investment Analysis By Top Players like GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc. and Merck & Co., Inc. here

News-ID: 1561062 • Views: 321

More Releases from Allied Market Research

Reed Sensor Market 2019–2026: Revenue Projections and Industry Insights | Stan …
Allied Market Research published the latest report, titled "Reed Sensor Market by Type (Dry-Reed Sensor, Mercury-Wetted Reed Sensor) and Application (Automotive, Transportation, Consumer Electronics, Robotics & Automation, Telecommunications, Healthcare, Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026." According to the report, reed sensor market is expected to witness significant growth during the forecast period due to surge in need for technological advancements in the sensors. The emergence of high-tech
Umbrella Market 2020 to Witness a Pronounce Growth During COVID-19 Crisis with D …
Umbrella also is known as parasol is an object used for protection against rain and sunlight. Umbrellas are usually designed for protection from rain whereas parasol is specifically designed and used to block the sunlight. Umbrellas are hand-held portable devices which come in different sizes, shapes, colors, and designs. These have been used since the seventeenth century and are considered as an essential accessory by most of the people. Canopy,
Forage Seed Market Size, Industry Analysis by Leading Key Players, Development a …
The global Forage Seed Market was valued at $11,683 million in 2015 and is projected to reach $20,646 million by 2022, growing at a CAGR of 8.50% from 2016 to 2022. In 2015, the alfalfa product segment held approximately more than one-fourth of the total market. Forage seeds are the edible parts of plants widely utilized for livestock feeding. Alfalfa, clover, chicory, ryegrass, lablab, and fescue are some of the popular
Cake Stand Market Expected To Be The Most Attractive Market During Upcoming Year …
A cake stand is a stool or an object that is used to decorate cakes or pastries. A cake stand can be single, double, and multi-tier based on occasion like birthday’s, weddings, and office parties. Cake stands can be of different sizes, shapes, and materials like wood, metal, and others. A cake stand works as a tool for making and displaying a cake in a better way. A cake stand

All 5 Releases


More Releases for CINV

CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the
CINV Existing and Pipeline Drugs Market is Expected to Surpass US$1.88 bn by 202 …
The global chemotherapy induced nausea and vomiting (CINV) drugs market is dominated by players such as Helsinn Holding S. A., Merck & Co. Inc., Tesaro Inc., and Heron Therapeutics, says Transparency Market Research (TMR) in a new study. Helsinn Holding S.A. along with its commercial partner Eisai Co. Ltd. led the overall CINV drugs market by revenue in 2013. The large companies are entering into a number of strategic alliances
Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Excellent Growth Scop …
A new research study from HTF MI with title Global Chemotherapy Induced Nausea and Vomiting ?CINV? Drugs Market Size, Status and Forecast 2025 provides an in-depth assessment of the Chemotherapy Induced Nausea and Vomiting ?CINV? Drugs including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Chemotherapy Induced Nausea and Vomiting ?CINV? Drugs investments till 2022. Access
CINV Existing and Pipeline Drugs Market will Surpass US$1.88 bn by 2020
The global chemotherapy induced nausea and vomiting (CINV) drugs market is dominated by players such as Helsinn Holding S. A., Merck & Co. Inc., Tesaro Inc., and Heron Therapeutics, says Transparency Market Research (TMR) in a new study. Helsinn Holding S.A. along with its commercial partner Eisai Co. Ltd. led the overall CINV drugs market by revenue in 2013. The large companies are entering into a number of strategic alliances
CINV Existing and Pipeline Drugs Market Projected to Reach US$1.88 bn by 2020
The global chemotherapy induced nausea and vomiting (CINV) drugs market is dominated by players such as Helsinn Holding S. A., Merck & Co. Inc., Tesaro Inc., and Heron Therapeutics, says Transparency Market Research (TMR) in a new study. Helsinn Holding S.A. along with its commercial partner Eisai Co. Ltd. led the overall CINV drugs market by revenue in 2013. The large companies are entering into a number of strategic alliances
Chemotherapy-induced Nausea and Vomiting (CINV) Market Grow $2, 659 Million By 2 …
Nausea and vomiting is one of the common side effects of chemotherapy in the cancer patients. Because of such side effects, the patient population either refuse or deferment the therapeutic chemotherapy treatment for cancer. For More Info, Get Sample: http://bit.ly/2zVmL28 The global Chemotherapy-induced Nausea and Vomiting market was valued at $1,663 million in 2015 and is estimated to reach $2, 659 million by 2022, registering a CAGR of 7.1%